About UGISense

UGISense AG is a biotech company dedicated to developing new and innovative antisense therapeutic agents in collaboration with partners from the industry and academia. The developments are made on the basis of a proprietary platform technology, i.e. the UgimeresTM. The company, which was first established in 2016, is being financed by private investors and has been accredited by the Federal Office of Economics and Export Control (BAFA) (within the scope of their Funds for Venture Capital program).

Facts about UGISense
  • Founding: 2016
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of UGISense

Product brands

Ugimere

Here you will find UGISense AG